NO20030481L - N-substituerte indol-3-glyoksylamider med antiastmatisk, antiallergisk og immunundertrykkende/immunmodulerende virkning - Google Patents

N-substituerte indol-3-glyoksylamider med antiastmatisk, antiallergisk og immunundertrykkende/immunmodulerende virkning

Info

Publication number: NO20030481L
Authority: NO; Norway
Prior art keywords: glyoxylamides; asthmatic; immunosuppressive; allergic; substituted indole
Prior art date: 1996-09-06

Application number

NO20030481A

Other languages

English (en)

Other versions

NO20030481D0 (no

Inventor

Guillaume Lebaut

Cecilia Menciu

Bernhard Kutscher

Peter Emig

Stefan Szelenyi

Kay Brune

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-06

Filing date

2003-01-30

Publication date

1999-03-04

1999-03-04 Publication of NO20030481L publication Critical patent/NO20030481L/no

2003-01-30 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

2003-01-30 Publication of NO20030481D0 publication Critical patent/NO20030481D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

NO20030481A 1996-09-06 2003-01-30 N-substituerte indol-3-glyoksylamider med antiastmatisk, antiallergisk og immunundertrykkende/immunmodulerende virkning NO20030481D0 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19636150A DE19636150A1 (de)	1996-09-06	1996-09-06	N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung

Publications (2)

Publication Number	Publication Date
NO20030481L true NO20030481L (no)	1999-03-04
NO20030481D0 NO20030481D0 (no)	2003-01-30

Family

ID=7804772

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19991071A NO314725B3 (no)	1996-09-06	1999-03-04	N-substituerte indol-3-glyoksylamider, deres fremstilling, anvendelse for fremstilling av medikamenter, legemidler inneholdende disse samt en fremgangsmate for fremstilling av et legemiddel
NO20030481A NO20030481D0 (no)	1996-09-06	2003-01-30	N-substituerte indol-3-glyoksylamider med antiastmatisk, antiallergisk og immunundertrykkende/immunmodulerende virkning

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO19991071A NO314725B3 (no)	1996-09-06	1999-03-04	N-substituerte indol-3-glyoksylamider, deres fremstilling, anvendelse for fremstilling av medikamenter, legemidler inneholdende disse samt en fremgangsmate for fremstilling av et legemiddel

Country Status (26)

Country	Link
US (4)	US6008231A (no)
EP (1)	EP0931063B3 (no)
JP (1)	JP3296437B2 (no)
KR (1)	KR100516321B1 (no)
CN (3)	CN101219985B (no)
AR (1)	AR008630A1 (no)
AT (1)	ATE342889T1 (no)
AU (1)	AU726521B2 (no)
BR (1)	BR9712808B1 (no)
CA (1)	CA2215013C (no)
CZ (1)	CZ302301B6 (no)
DE (2)	DE19636150A1 (no)
DK (1)	DK0931063T5 (no)
ES (1)	ES2276433T7 (no)
HU (1)	HU227797B1 (no)
IL (1)	IL127798A (no)
NO (2)	NO314725B3 (no)
NZ (1)	NZ334476A (no)
PT (1)	PT931063E (no)
RU (1)	RU2237661C2 (no)
SK (1)	SK285618B6 (no)
TR (1)	TR199900469T2 (no)
TW (1)	TW550256B (no)
UA (1)	UA60312C2 (no)
WO (1)	WO1998009946A1 (no)
ZA (1)	ZA977475B (no)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19636150A1 (de) *	1996-09-06	1998-03-12	Asta Medica Ag	N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
CA2383983C (en) *	1998-03-31	2009-09-29	The Institutes For Pharmaceutical Discovery, Llc	Substituted indolealkanoic acids
DE19814838C2 (de) *	1998-04-02	2001-01-18	Asta Medica Ag	Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
CZ302588B6 (cs) *	1998-04-02	2011-07-27	Ziopharm Oncology, Inc.	Použití N-substituovaného indol-3-glyoxylamidu pro výrobu léciva
DE19946301A1 (de)	1998-04-02	2001-04-19	Asta Medica Ag	Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften
DE19917504A1 (de) *	1999-04-17	2000-10-19	Dresden Arzneimittel	Verwendung von Hydroxyindolen, die Inhibitoren der Phosphodiesterase 4 sind, zur Therapie chronisch obstruktiver Lungenerkrankungen
DE19818964A1 (de) *	1998-04-28	1999-11-04	Dresden Arzneimittel	Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
TR200003130T2 (tr) *	1998-04-28	2001-01-22	Arzneimittelwerk Dresden Gmbh	Yeni hidroksiindoller, bunların fosfodiesteraz 4 inhibitörleri olarak kullanımları ve hazırlanmaları için işlemler
CZ302882B6 (cs)	1999-08-21	2012-01-04	Nycomed Gmbh	Farmaceutický prostredek
TWI269654B (en) *	1999-09-28	2007-01-01	Baxter Healthcare Sa	N-substituted indole-3-glyoxylamide compounds having anti-tumor action
DE19962300A1 (de) *	1999-12-23	2001-06-28	Asta Medica Ag	Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
DE10022925A1 (de) *	2000-05-11	2001-11-15	Basf Ag	Substituierte Indole als PARP-Inhibitoren
DE10037310A1 (de)	2000-07-28	2002-02-07	Asta Medica Ag	Neue Indolderivate und deren Verwendung als Arzneimittel
AU2002323474B2 (en) *	2001-09-13	2006-10-05	Synta Pharmaceuticals Corp	3-glyoxlylamideindoles for treating cancer
RU2337906C2 (ru) *	2001-12-03	2008-11-10	Уайт	Ингибиторы цитозольной фосфолипазы а2
US6903104B2 (en) *	2001-12-06	2005-06-07	National Health Research Institutes	Indol-3-YL-2-oxoacetamide compounds and methods of use thereof
MXPA05001011A (es) *	2002-07-26	2005-06-08	Inst For Pharm Discovery Inc	Derivado de acidos indolalcanoicos substituidos y formulaciones que lo contienen para uso en tratamiento de complicaciones diabeticas.
HRP20050201A2 (en) *	2002-08-01	2005-04-30	Elbion Ag	Method for producing highly pure hydroxy indolyl glyoxylic acid amideslyoxylic acid amides
DE10253426B4 (de) *	2002-11-15	2005-09-22	Elbion Ag	Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
BRPI0409229A (pt)	2003-04-01	2006-03-28	Applied Research Systems	inibidores das fosfodiesterases na infertilidade
DE10318610A1 (de) *	2003-04-24	2004-11-11	Elbion Ag	7-Azaindole und deren Verwendung als Therapeutika
DE10318609A1 (de) *	2003-04-24	2004-11-11	Elbion Ag	5-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
DE10318611A1 (de)	2003-04-24	2004-11-11	Elbion Ag	4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
US20050075364A1 (en) *	2003-07-01	2005-04-07	Kap-Sun Yeung	Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
DE10334040A1 (de) *	2003-07-25	2005-03-10	Zentaris Gmbh	Neue N-substituierte Indolyl-3-glyoxylsäureamide, deren Verwendung als Arzneimittel und Verfahren zu deren Herstellung
WO2005023761A2 (en)	2003-09-11	2005-03-17	Kemia, Inc.	Cytokine inhibitors
EP2583678A3 (en)	2004-06-24	2013-11-13	Novartis Vaccines and Diagnostics, Inc.	Small molecule immunopotentiators and assays for their detection
DE102004031538A1 (de) *	2004-06-29	2006-02-09	Baxter International Inc., Deerfield	Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
WO2006052712A1 (en) *	2004-11-08	2006-05-18	Baxter International Inc.	Nanoparticulate compositions of tubulin inhibitor
US20060100209A1 (en) *	2004-11-09	2006-05-11	Chong-Hui Gu	Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100432A1 (en) *	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US8604055B2 (en)	2004-12-31	2013-12-10	Dr. Reddy's Laboratories Ltd.	Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
US9040558B2 (en)	2004-12-31	2015-05-26	Dr. Reddy's Laboratories Ltd.	Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
JP2006247963A (ja) *	2005-03-09	2006-09-21	Oji Paper Co Ltd	インクジェット記録用シート
US8242149B2 (en) *	2005-03-11	2012-08-14	Vertex Pharmaceuticals Incorporated	Modulators of ATP-binding cassette transporters
US7328672B2 (en)	2005-04-29	2008-02-12	Tendik Development, Llc	Radial impulse engine, pump, and compressor systems, and associated methods of operation
US20060280787A1 (en) *	2005-06-14	2006-12-14	Baxter International Inc.	Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US7598380B2 (en) *	2005-08-03	2009-10-06	Bristol-Myers Squibb Company	Method of preparation of azaindole derivatives
ITMI20051999A1 (it) *	2005-10-21	2007-04-22	Eratech S R L	Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
US7851476B2 (en) *	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en)	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
RS53084B (sr)	2006-07-05	2014-06-30	Takeda Gmbh	Kombinacija inhibitora hmg-coa reduktaze rosuvastatina sa inhibitorom fosfodiesteraze 4, kao što je roflumilast, roflumilast-n-oksid za lečenje inflamatornih plućnih obolenja
WO2008019357A2 (en) *	2006-08-07	2008-02-14	Ironwood Pharmaceuticals, Inc.	Indole compounds
EP2066619A2 (en) *	2006-11-02	2009-06-10	Arete Therapeutics, INC.	Soluble epoxide hydrolase inhibitors
CA2670778A1 (en) *	2006-11-28	2008-06-05	Ziopharm Oncology, Inc.	Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
MX2011011517A (es)	2009-04-29	2012-06-19	Amarin Corp Plc	Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
AR084433A1 (es)	2010-12-22	2013-05-15	Ironwood Pharmaceuticals Inc	Inhibidores de la faah y composiciones farmaceuticas que los contienen
US9199967B2 (en)	2011-08-18	2015-12-01	Dr. Reddy's Laboratories Ltd.	Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (CETP) inhibitors
IN2014CN02290A (no)	2011-09-27	2015-06-19	Reddys Lab Ltd Dr
EP3165224A1 (en)	2015-11-09	2017-05-10	Albert-Ludwigs-Universität Freiburg	Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en)	2015-11-25	2017-06-01	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
CN109000634B (zh) *	2018-06-04	2022-06-03	上海智蕙林医疗科技有限公司	一种导航对象行进路线的提醒方法和系统

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB797258A (en) *	1955-04-11	1958-06-25	Upjohn Co	3-substituted indoles
GB944443A (no) *	1959-09-25	1900-01-01
GB1028812A (en) *	1962-08-28	1966-05-11	Ici Ltd	Indole derivatives
GB1089071A (en) *	1964-02-28	1967-11-01	Merck & Co Inc	Indole derivatives
US3686213A (en) *	1970-08-28	1972-08-22	American Cyanamid Co	Substituted aminoethyl indoles
SU457698A1 (ru) *	1972-10-20	1975-01-25	Всесоюзный научно-исследовательский химико-фармацевтический институт им. Серго Орджоникидзе	Способ получени производных индолил-2-уксусной кислоты
FR2689888B1 (fr) *	1992-04-10	1994-06-10	Rhone Poulenc Rorer Sa	Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
RU2128169C1 (ru) *	1994-04-01	1999-03-27	Эли Лилли Энд Компани	Iн-индол-3-глиоксиламиды, ингибирующие spla2-медиируемое выделение жирных кислот, фармацевтическая композиция
DE19636150A1 (de) *	1996-09-06	1998-03-12	Asta Medica Ag	N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
DE19946301A1 (de) *	1998-04-02	2001-04-19	Asta Medica Ag	Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften
US7205299B2 (en) *	2003-06-05	2007-04-17	Zentaris Gmbh	Indole derivatives having an apoptosis-inducing effect

1996
- 1996-09-06 DE DE19636150A patent/DE19636150A1/de not_active Ceased
1997
- 1997-08-16 IL IL12779897A patent/IL127798A/xx not_active IP Right Cessation
- 1997-08-16 TR TR1999/00469T patent/TR199900469T2/xx unknown
- 1997-08-16 DE DE59712752T patent/DE59712752D1/de not_active Expired - Lifetime
- 1997-08-16 RU RU99106782A patent/RU2237661C2/ru not_active IP Right Cessation
- 1997-08-16 DK DK97937586T patent/DK0931063T5/da active
- 1997-08-16 AU AU40158/97A patent/AU726521B2/en not_active Ceased
- 1997-08-16 CN CN2008100087226A patent/CN101219985B/zh not_active Expired - Fee Related
- 1997-08-16 CN CNB021320616A patent/CN100488948C/zh not_active Expired - Fee Related
- 1997-08-16 NZ NZ334476A patent/NZ334476A/xx not_active IP Right Cessation
- 1997-08-16 CN CNB971971285A patent/CN100376554C/zh not_active Expired - Fee Related
- 1997-08-16 CZ CZ0061699A patent/CZ302301B6/cs not_active IP Right Cessation
- 1997-08-16 PT PT97937586T patent/PT931063E/pt unknown
- 1997-08-16 SK SK271-99A patent/SK285618B6/sk not_active IP Right Cessation
- 1997-08-16 UA UA99041907A patent/UA60312C2/uk unknown
- 1997-08-16 KR KR10-1999-7001909A patent/KR100516321B1/ko not_active Expired - Fee Related
- 1997-08-16 JP JP51216798A patent/JP3296437B2/ja not_active Expired - Fee Related
- 1997-08-16 EP EP97937586A patent/EP0931063B3/de not_active Expired - Lifetime
- 1997-08-16 HU HU9903741A patent/HU227797B1/hu not_active IP Right Cessation
- 1997-08-16 BR BRPI9712808-2A patent/BR9712808B1/pt not_active IP Right Cessation
- 1997-08-16 WO PCT/EP1997/004474 patent/WO1998009946A1/de not_active Ceased
- 1997-08-16 AT AT97937586T patent/ATE342889T1/de active
- 1997-08-16 ES ES97937586T patent/ES2276433T7/es active Active
- 1997-08-20 ZA ZA9707475A patent/ZA977475B/xx unknown
- 1997-09-04 CA CA002215013A patent/CA2215013C/en not_active Expired - Fee Related
- 1997-09-05 AR ARP970104064A patent/AR008630A1/es active IP Right Grant
- 1997-09-08 US US08/925,326 patent/US6008231A/en not_active Expired - Lifetime
- 1997-09-30 TW TW086112985A patent/TW550256B/zh not_active IP Right Cessation
1999
- 1999-03-04 NO NO19991071A patent/NO314725B3/no not_active IP Right Cessation
- 1999-09-30 US US09/409,263 patent/US6344467B1/en not_active Expired - Lifetime
2002
- 2002-01-30 US US10/058,836 patent/US20020161025A1/en not_active Abandoned
2003
- 2003-01-30 NO NO20030481A patent/NO20030481D0/no not_active Application Discontinuation
- 2003-04-01 US US10/402,931 patent/US6919344B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE19636150A1 (de)	1998-03-12
ZA977475B (en)	1998-02-19
CN1496980A (zh)	2004-05-19
DE59712752D1 (de)	2006-11-30
PT931063E (pt)	2007-02-28
AU726521B2 (en)	2000-11-09
CN101219985B (zh)	2011-04-27
AU726521C (en)	1998-03-26
ES2276433T3 (es)	2007-06-16
CN100376554C (zh)	2008-03-26
AR008630A1 (es)	2000-02-09
JP2000505098A (ja)	2000-04-25
IL127798A (en)	2003-07-31
CA2215013C (en)	2002-03-05
CZ61699A3 (cs)	1999-06-16
IL127798A0 (en)	1999-10-28
DK0931063T3 (da)	2007-02-19
UA60312C2 (uk)	2003-10-15
NO314725B1 (no)	2003-05-12
AU4015897A (en)	1998-03-26
ATE342889T1 (de)	2006-11-15
NO991071D0 (no)	1999-03-04
RU2237661C2 (ru)	2004-10-10
HU227797B1 (en)	2012-03-28
TW550256B (en)	2003-09-01
ES2276433T7 (es)	2009-11-05
US6008231A (en)	1999-12-28
NO991071L (no)	1999-03-04
HUP9903741A2 (hu)	2000-04-28
EP0931063B3 (de)	2009-04-08
KR100516321B1 (ko)	2005-09-23
CN1227542A (zh)	1999-09-01
CN101219985A (zh)	2008-07-16
CZ302301B6 (cs)	2011-02-09
KR20000068495A (ko)	2000-11-25
HUP9903741A3 (en)	2001-01-29
BR9712808A (pt)	1999-11-23
EP0931063A1 (de)	1999-07-28
US6919344B2 (en)	2005-07-19
JP3296437B2 (ja)	2002-07-02
HK1021641A1 (zh)	2000-06-23
US20030207892A1 (en)	2003-11-06
HK1064379A1 (zh)	2005-01-28
US20020161025A1 (en)	2002-10-31
EP0931063B1 (de)	2006-10-18
CA2215013A1 (en)	1998-03-06
TR199900469T2 (xx)	1999-05-21
BR9712808B1 (pt)	2009-05-05
NO314725B3 (no)	2009-03-09
SK27199A3 (en)	1999-08-06
NO20030481D0 (no)	2003-01-30
HK1123280A1 (en)	2009-06-12
DK0931063T5 (da)	2010-01-11
WO1998009946A1 (de)	1998-03-12
US6344467B1 (en)	2002-02-05
SK285618B6 (sk)	2007-05-03
CN100488948C (zh)	2009-05-20
NZ334476A (en)	2000-05-26

Publication	Publication Date	Title
NO20030481D0 (no)	2003-01-30	N-substituerte indol-3-glyoksylamider med antiastmatisk, antiallergisk og immunundertrykkende/immunmodulerende virkning
DE69732084D1 (de)	2005-02-03	Pulsladeverfahren und ladegerät
DE59711118D1 (de)	2004-01-22	Spickeln, Zunehmen und Mindern
DE69532501D1 (de)	2004-03-04	Verbessertes, langwirkendes gastrointestinales und ösophagisches schutzmittel
ZA976222B (en)	1998-01-19	N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
DE69738197D1 (de)	2007-11-22	Azolotriazine und pyrimidine
ZA977901B (en)	1998-03-25	Heterocyclic esters and amides.
DE69725961D1 (de)	2003-12-11	Befestigumgsvorrichtung und damit versehene prothese
DE69526002D1 (de)	2002-05-02	Aufladegerät und Aufladevorrichtung
NO971076D0 (no)	1997-03-07	Totrinns filtreringssystem med keramisk skum, og fremgangsmåte
DE69534816D1 (de)	2006-04-27	Integrale radio- und infrarot-hörhilfevorrichtung
FI971884A7 (fi)	1997-07-02	Tietoliikennemenetelmä ja -järjestely
FI952009L (fi)	1995-10-28	N-(2-amino-4,6-diklooripyrimidin-5-yyli) formamidi sekä menetelmä sen valmistamiseksi
DE69727047D1 (de)	2004-02-05	Entpaketierer und rahmenausgleicher damit
NO964541L (no)	1996-12-23	Porphacyanin og CNC-utvidete porphyriner
DE69713817D1 (de)	2002-08-14	Schutzabdeckung und damit ausgestatteter Apparat
NO985806D0 (no)	1998-12-11	Kitinasematerialer og fremgangsmÕter
DE69716328D1 (de)	2002-11-21	Elektroplattierungsverfahren und Zusammenstellung
DE69532056D1 (de)	2003-12-11	Signalgenerator und drahtloses Mobilsystem damit
DE69842206D1 (de)	2011-05-12	Echounterdrücker und echounterdrückungsverfahren
NO20003268D0 (no)	2000-06-22	Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
NO991279D0 (no)	1999-03-16	Sirkulµrt t°rkeelement og t°rkeanlegg med slikt t°rkeelement
DE59706929D1 (de)	2002-05-16	Balancier-Hebegerät
DK1042286T3 (da)	2010-12-13	Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
DE69420653D1 (de)	1999-10-21	Verstärkerkette in Strommode, Operationsverstärker, Verstärkungszelle und zugehöriges Verstärkerelement

Legal Events

Date	Code	Title	Description
2005-10-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application